Compound 1369
Identifiers
- Canonical SMILES:
CNC(=O)[C@@H]1C[C@@H](CN1C(=O)[C@@H]1C[C@@H](CN1C(=O)[C@H](Cc1ccco1)NC(=O)[C@H](C)N)c1ccccc1)c1ccccc1
- IUPAC name:
(2S,4R)-1-[(2S,4R)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(furan-2-yl)propanoyl]-4-phenylpyrrolidine-2-carbonyl]-N-methyl-4-phenylpyrrolidine-2-carboxamide
- InChi:
InChI=1S/C33H39N5O5/c1-21(34)30(39)36-27(18-26-14-9-15-43-26)32(41)38-20-25(23-12-7-4-8-13-23)17-29(38)33(42)37-19-24(16-28(37)31(40)35-2)22-10-5-3-6-11-22/h3-15,21,24-25,27-29H,16-20,34H2,1-2H3,(H,35,40)(H,36,39)/t21-,24-,25-,27-,28-,29-/m0/s1
- InChiKey:
ZQHAPJQAUKHRKR-YGQTVEAASA-N
External links
![]() 58436641 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 585.30 g/mol | |||
HBA | 10 | |||
HBD | 4 | |||
HBA + HBD | 14 | |||
AlogP | 1.26 | |||
TPSA | 137.98 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152824 | 15 | XIAP P98170 |
|
Biochemical assay | alphascreen | pIC50 (half maximal inhibitory concentration, -log10) | 8.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6372 | PPI-1019 | DB05832 | |
0.6239 | N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide | DB08187 | |
0.6154 | beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide | DB07083 | |
0.6116 | (3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione | DB04520 | |
0.6018 | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE | DB07749 | |
0.5969 | NRX-1074 | DB11784 | |
0.5785 | 1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) | DB08119 | |
0.5760 | D-phenylalanyl-N-benzyl-L-prolinamide | DB07143 | |
0.5606 | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide | DB07005 | |
0.5581 | D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide | DB07133 | |
0.5572 | Difelikefalin | DB11938 | |
0.5530 | D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide | DB07027 | |
0.5530 | [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE | DB08422 | |
0.5504 | Apstatin | DB04092 | |
0.5489 | D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide | DB06919 |